Matsubayashi Hiroyuki, Kishida Yoshihiro, Imai Kenichiro, Hotta Kinichi, Kakushima Naomi, Tanaka Masaki, Takizawa Kohei, Ono Hiroyuki
Division of Endoscdopy, Shizuoka Cancer Center, Nagaizum i, Suntogun, Shizuoka, Japan.
Saudi J Gastroenterol. 2014 May-Jun;20(3):199-201. doi: 10.4103/1319-3767.133035.
The stenting strategy has been discussed in cases with unresectable hilar bile duct cancer (HBDC). We describe here a case of HBDC, 4 cm in size, invading the right portal vein and hepatic artery, which was only treated with repeated metallic stent placement, and the patient survived for a long period (51 months). Against Bismuth type-IV hilar biliary stricture, our strategy was to maintain the drainage of the largest, viable hepatic area (>50% of total liver) by unilateral multiple stent-in-stent.
对于无法切除的肝门部胆管癌(HBDC)病例,已经讨论过支架置入策略。我们在此描述一例大小为4 cm、侵犯右门静脉和肝动脉的HBDC病例,该病例仅接受了多次金属支架置入治疗,患者存活了很长时间(51个月)。针对Bismuth IV型肝门部胆管狭窄,我们的策略是通过单侧多个支架套叠来维持最大的存活肝区(>全肝的50%)的引流。